SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000320017-23-000063
Filing Date
2023-11-02
Accepted
2023-11-02 16:11:38
Documents
79
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lsta-20230930.htm   iXBRL 10-Q 1009063
2 EX-31.1 lsta-ex311_20230930.htm EX-31.1 9569
3 EX-32 lsta-ex32_20230930.htm EX-32 6891
9 lsta-20230930_g1.jpg GRAPHIC 149635
10 lsta-20230930_g2.jpg GRAPHIC 105817
  Complete submission text file 0000320017-23-000063.txt   6619191

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lsta-20230930.xsd EX-101.SCH 50132
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lsta-20230930_cal.xml EX-101.CAL 60522
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lsta-20230930_def.xml EX-101.DEF 186333
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lsta-20230930_lab.xml EX-101.LAB 603217
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lsta-20230930_pre.xml EX-101.PRE 387616
73 EXTRACTED XBRL INSTANCE DOCUMENT lsta-20230930_htm.xml XML 765170
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33650 | Film No.: 231372421
SIC: 2834 Pharmaceutical Preparations